The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk
about
Hydralazine for essential hypertensionSpironolactone for hypertensionHydralazine for essential hypertensionMethyldopa for primary hypertensionMethyldopa for essential hypertensionHydralazine for essential hypertensionSpironolactone for hypertensionThe 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of riskThe 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of riskKnowledge, attitudes and behaviours related to dietary sodium among 35- to 50-year-old Ontario residentsBlood pressure measurement guidelines for physical therapists.Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelinesPregnant women with gestational hypertension may have a high frequency of sleep disordered breathing.Process description and evaluation of Canadian Physical Activity Guidelines development.Tackling the burden of hypertension in Canada: encouraging collaborative careCardiovascular dysfunctions and sympathovagal imbalance in hypertension and prehypertension: physiological perspectives.Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs.S’attaquer au fardeau de l’hypertension au Canada: Encourager les soins en collaboration.Fluid Redistribution in Sleep Apnea: Therapeutic Implications in Edematous States.
P2860
Q24235133-FF426212-B35C-4D21-9963-61FD10A90CE5Q24236324-3A34D466-D1DC-40D7-B02E-E0BC3E4BED6CQ24236445-FD5DB74F-6250-4F6F-8B8A-1929A618A5D5Q24240065-4D7EDC85-7A7D-4AE7-9253-E0573ACBB2F1Q24240556-B91691BE-4CAF-4D05-B6B3-E368DD2CEE38Q24240813-96407701-A6FB-4247-81EF-757A6CA9928CQ24241409-2BF7EFC5-9E10-4926-940D-36D6CFD0E2B5Q24651499-093D534E-47DC-4A9C-BC51-BFF70A7090E1Q33916671-B08F1B84-C68C-4C16-B80A-1146C16962F2Q33916712-2D2F9260-DDDC-4EDF-A968-2CBC38B125E2Q35016318-48A994DE-2BD4-4482-BF91-88A31CA6855DQ35102589-EB909E15-B064-45FF-9068-145D144E4583Q35110541-947C8D5B-1443-4723-BA0C-E8FAEC543ED9Q35575293-75125BE5-2D0F-4316-9B98-144C13725D9FQ37014407-481BFE79-241D-4306-BE6A-FD33DECAFDD6Q38069200-6D2F0EB5-9FB2-4A7C-BFDC-4F5400E65206Q43743819-CD290A4B-4911-46AD-87A5-D4C728426D60Q45885930-9D7B3B00-81EC-43DF-8CB6-900A9313E1EEQ48505927-F19DF970-2BA7-470B-B244-0BC08BAB7DD0
P2860
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@ast
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@en
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@nl
type
label
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@ast
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@en
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@nl
prefLabel
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@ast
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@en
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@nl
P2093
P2860
P50
P1476
The 2008 Canadian Hypertension ...... agnosis and assessment of risk
@en
P2093
Alain Milot
Arun Chockalingam
Brenda R Hemmelgarn
Brian Penner
Canadian Hypertension Education Program
Carl Abbott
Donald W McKay
Ellen Burgess
Ernesto L Schiffrin
Finlay A McAlister
P2860
P304
P356
10.1016/S0828-282X(08)70619-6
P407
P577
2008-06-01T00:00:00Z